New benzimidazole derivatives as topoisomerase i inhibitors - Synthesis and fluorometric analysis

Acta Poloniae Pharmaceutica - Drug Research

Volumn 70, Issue 3, 2013, Pages 451-458

  Błaszczak Swiatkiewicz, Katarzyna ^a   Mikiciuk Olasik, Elzbieta ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Anticancer activity; Benzmidazole; Inhibitors of topoisomerase I; Nitrobenzimidazole

Indexed keywords

2 (4 CHLOROPHENYL) 5 NITRO 1H BENZIMIDAZOLE N OXIDE; 2 (5 NITRO 1H BENZIMIDAZOL 2 YL) BENZOIC ACID N OXIDE; 2 BENZO[1,3]DIOXOL 5 YL 5 CHLORO 1H BENZIMIDAZOLE; 2 BENZO[1.3]DIOXOL 5 YL 5 NITRO 1H BENZIMIDAZOLE N OXIDE; 2 NAPHTHYL 5 NITRO 1H BENZIMIDAZOLE N OXIDE; 5 CHLORO 2 NAPHTHYL 1H BENZOIMIDAZOLE; 5 NITRO 2 (2 NITROPHENYL) 1H BENZIMIDAZOLE; 5 NITRO 2 (2 NITROPHENYL) 1H BENZIMIDAZOLE N OXIDE; 5 NITRO 2 CARBOXYPHENYL 1H BENZIMIDAZOLE; BENZIMIDAZOLE DERIVATIVE; CAMPTOTHECIN; DNA TOPOISOMERASE; DNA TOPOISOMERASE INHIBITOR; PLASMID DNA; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ANTINEOPLASTIC ACTIVITY; ARTICLE; DRUG SYNTHESIS; ENZYME INHIBITION; FLUOROMETRY; IN VITRO STUDY; PROCESS OPTIMIZATION; QUANTITATIVE ANALYSIS; VALIDATION PROCESS;

BENZIMIDAZOLES; FLUOROMETRY; TOPOISOMERASE I INHIBITORS;

EID: 84878090874     PISSN: 00016837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Baszczak-awîtkiewicz K., Mikiciuk-Olasik E.: Wiad. Chem. 62, 1065 (2008).
2. McKeown S.R., Cowen R.L., Williams K.J.: Clin. Oncol. 19, 427 (2007).
3. Albertella M.R., Loadman P.M., Jones P.H.: Clin. Cancer Res. 14, 1096 (2008).
4. Baszczak-awîtkiewicz K., Olszewska P., Mikiciuk-Olasik E.: Nowotwory Journal of Oncology 62, 188 (2012).
5. azowski J.: Farm. Pol. 55, 28 (1999).
6. Pommier Y.: Nat. Rev. Cancer 6, 789 (2006).
7. Meng L., Liao Z., Pommier Y.: Curr. Top. Med. Chem. 3, 305 (2003).
8. Kurtzberg L.S., Roth S., Krumbholz R.: Clin. Cancer Res. 17, 2777 (2011).
9. Alpan A.S., Gunes H.S., Topcu Z.: Acta Biochim. Pol. 54, 561 (2007).
10. Omya-Staszewska J., Deptaa A.: WspUcz. Onkol. 7, 45 (2003).
11. Wu N., Wu X., Agama K.: Biochemistry 49, 10131 (2010).
12. Coban G., Zencir S., Zupkoz I., Rethy B., Gunes H.S., Topcu Z.: Eur. J. Med. Chem. 44, 2280 (2009).
13. Alpan A.S., Zupkoz I., Coban G., Rethy B., Gunes H.S., Topcu Z.: J. Enzyme Inhib. Med. Chem. 24, 3, 844 (2009).
14. Singh M., Tandon V.: Eur. J. Med. Chem. 46, 659 (2011).
15. Alper S., Arpaci O. T., Aki E. S., Yalcin I.: Farmaco 58, 497 (2003).
16. Oksuzoglu E., Tekiner-Gulbas B., Amper S.: J. Enzyme Inhib. Med. Chem. 23, 1, 37 (2008).
17. Jerchel D., Fischer H., Kracht M., Justus Liebigs Ann. Chem. 575, 162 (1952).
18. Panieres G. C., Bonifas I.A., Guadalupe J.C., Lopez. J.E.: Synth. Commun. 30, 2195 (2000).
19. Preston P.N.: Chem. Rev. 74, 3 (1974).
20. Baszczak-awîtkiewicz K., Mirowski M., KapliOska K., KruszyOski R., TrzIsowska- KruszyOska A., Mikiciuk-Olasik E.: Acta Biochim. Pol. 59, 279 (2012).
21. Mikiciuk-Olasik E., Baszczak-awîtkiewicz K., Ourek E., Krajewskaz U., RUoalski M., KruszyOski R., Bartczak T. J.: Arch. Pharm. Pharm. Med. Chem. 337, 239 (2004).
22. Foglesong P. D.: Anal. Biochem. 182, 284 (1989).
23. Baszczak-awîtkiewicz K., Mikiciuk-Olasik E.: J. Liq. Chromatogr. Relat. Technol. 34, 1901 (2011).
24. Budzisz E., Miernicka M., Lorenz I.P., Mayer P., Balcerzak E., Krajewskaz U., Rozalski M.: Eur. J. Med. Chem. 45, 2613 (2010).